These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Autoimmune inner ear disease: steroid and cytotoxic drug therapy. Lasak JM, Sataloff RT, Hawkshaw M, Carey TE, Lyons KM, Spiegel JR. Ear Nose Throat J; 2001 Nov 08; 80(11):808-11, 815-6, 818 passim. PubMed ID: 11816893 [Abstract] [Full Text] [Related]
7. Relapsing autoimmune inner ear disease with significant response to methotrexate and azathioprine combination therapy: A case report and mini literature review. Huang KH, Lin HC, Lin CD, Wu PC. Medicine (Baltimore); 2023 Jun 09; 102(23):e33889. PubMed ID: 37335659 [Abstract] [Full Text] [Related]
9. Cochlin in autoimmune inner ear disease: is the search for an inner ear autoantigen over? Baruah P. Auris Nasus Larynx; 2014 Dec 09; 41(6):499-501. PubMed ID: 25199741 [Abstract] [Full Text] [Related]
10. Etanercept treatment for autoimmune inner ear disease: results of a pilot placebo-controlled study. Cohen S, Shoup A, Weisman MH, Harris J. Otol Neurotol; 2005 Sep 09; 26(5):903-7. PubMed ID: 16151336 [Abstract] [Full Text] [Related]
12. Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss. Street I, Jobanputra P, Proops DW. J Laryngol Otol; 2006 Dec 09; 120(12):1064-6. PubMed ID: 17040588 [Abstract] [Full Text] [Related]
13. Autoimmune inner ear disease (AIED): A diagnostic challenge. Ciorba A, Corazzi V, Bianchini C, Aimoni C, Pelucchi S, Skarżyński PH, Hatzopoulos S. Int J Immunopathol Pharmacol; 2018 Dec 09; 32():2058738418808680. PubMed ID: 30376736 [Abstract] [Full Text] [Related]
14. Alternatives to systemic steroid therapy for refractory immune-mediated inner ear disease: A physiopathologic approach. García-Berrocal JR, Ibáñez A, Rodríguez A, González-García JA, Verdaguer JM, Trinidad A, Ramírez-Camacho R. Eur Arch Otorhinolaryngol; 2006 Nov 09; 263(11):977-82. PubMed ID: 16802138 [Abstract] [Full Text] [Related]
15. Autoimmune inner ear disease: diagnostic and therapeutic approaches in a multidisciplinary setting. Matteson EL, Fabry DA, Strome SE, Driscoll CL, Beatty CW, McDonald TJ. J Am Acad Audiol; 2003 Nov 09; 14(4):225-30. PubMed ID: 12940706 [Abstract] [Full Text] [Related]
16. Corticosteroid response and supporting cell antibody in autoimmune hearing loss. Zeitoun H, Beckman JG, Arts HA, Lansford CD, Lee DS, El-Kashlan HK, Telian SA, Denny DE, Ramakrishnan A, Nair TS, Disher MJ, Sataloff RT, Fisher SG, Carey TE. Arch Otolaryngol Head Neck Surg; 2005 Aug 09; 131(8):665-72. PubMed ID: 16103296 [Abstract] [Full Text] [Related]
18. Pediatric fluctuating sensorineural hearing loss: problems in medical management. Dinces EA, Yang S, Balogun AO. Laryngoscope; 2001 Jan 09; 111(1):21-5. PubMed ID: 11192894 [Abstract] [Full Text] [Related]
19. The Clinician Faced With Anticochlear Antibodies: What to Do With Them? Carlomagno A, Silveira G, Rebella M, Vola M, Danza A. J Clin Rheumatol; 2018 Apr 09; 24(3):113-115. PubMed ID: 29116948 [Abstract] [Full Text] [Related]
20. Pediatric Autoimmune Inner Ear Disease: A Rare, But Treatable Condition. Oz RS, Gluth M, Tesher MS. Pediatr Ann; 2019 Oct 01; 48(10):e391-e394. PubMed ID: 31609997 [Abstract] [Full Text] [Related] Page: [Next] [New Search]